Andrew Dick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 Key Deer Blvd, Big Pine Key, FL 33043 Phone: 305-872-4850 |
Larry Myers Poyer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30351 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-1371 |
Kathleen Mills Ray, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30351 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-1371 |
Janice Czerwinski, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30401 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-3797 Fax: 305-872-1981 |
Dr. Kevin Brady Schmida, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30351 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-1371 |
Gary Knoss Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 Key Deer Blvd, Big Pine Key, FL 33043 Phone: 305-872-4850 Fax: 305-872-4995 |
Mrs. Stephanie A White, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 Key Deer Blvd, Big Pine Key, FL 33043 Phone: 305-872-4850 |
News Archive
As a nurse clinician in the comprehensive hemophilia treatment center at Nationwide Children's Hospital for nearly 30 years, Charmaine Biega, RN, has watched her patients endure hundreds of needle sticks for infusions and other procedures which can mean tears, frustration, wiggling and - in some cases - lifelong anxiety about the medical system and treatments that patients with hemophilia need to survive.
Sam Houston State University has applied for six federal patents, three of which have already been awarded, to protect the technology and engineering associated with a "revolutionary" packaged wastewater treatment system invented by its scientists, and it has formed a company to further develop, market and sell the systems.
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec). Moreover, their findings point to genes that could be suppressed in order to make these tumors respond more readily to imatinib.
› Verified 3 days ago